Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: August 8, 2022

Investigational Drug Information for Benzoylecgonine

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the drug development status for Benzoylecgonine?

Benzoylecgonine is an investigational drug.

There have been 18 clinical trials for Benzoylecgonine. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1^st 2011.

The most common disease conditions in clinical trials are Cocaine-Related Disorders, Impulsive Behavior, and Renal Insufficiency. The leading clinical trial sponsors are National Institute on Drug Abuse (NIDA), University of Pennsylvania, and Cincinnati MDRU.

Summary for Benzoylecgonine

US Patents	0
International Patents	0
US Patent Applications	3,903
WIPO Patent Applications	1,269
Japanese Patent Applications	516
Clinical Trial Progress	Phase 3 (2011-05-01)
Vendors	16

Recent Clinical Trials for Benzoylecgonine

Title	Sponsor	Phase
Trial Of NS2359 For The Treatment of Cocaine Dependence	Saniona	Phase 2
Trial Of NS2359 For The Treatment of Cocaine Dependence	The Dana Foundation	Phase 2
Trial Of NS2359 For The Treatment of Cocaine Dependence	University of Pennsylvania	Phase 2

See all Benzoylecgonine clinical trials

Clinical Trial Summary for Benzoylecgonine

Top disease conditions for Benzoylecgonine

Top clinical trial sponsors for Benzoylecgonine

See all Benzoylecgonine clinical trials

US Patents for Benzoylecgonine

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign up for a Free Trial
Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
>Drugname	>Patent Number	>Patent Title	>Patent Assignee	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt

Colorcon

Harvard Business School

Johnson and Johnson

McKinsey

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.